← All companies
ASTH
Astrana Health, Inc.
$35.91
-0.77 -2.10%
Key statistics
from XBRL data in SEC filingsMarket cap
$2.00B
Revenue (TTM)
$3.53B
Net income (TTM)
$31.7M
EPS (TTM)
$0.61
P/E ratio
58.9
Dividend yield
—
Free cash flow
$104M
Cash
$478M
Total assets
$2.36B
Gross margin
0.0%
52-week range
$18.08 – $51.60
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 13, 2026
8-K
Director or officer change
Jul 1, 2026
8-K
Director or officer change; Shareholder vote results
Jun 10, 2026
8-K
Director or officer change
May 12, 2026
8-K
Regulation FD disclosure
May 12, 2026
10-Q
Quarter ended 2026-03-31
May 8, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2026
8-K
Other events
Mar 30, 2026
10-K
Fiscal year ended 2025-12-31
Mar 12, 2026
8-K
Regulation FD disclosure
Mar 4, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Mar 2, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 6, 2025
8-K/A
FORM 8-K/A
Sep 11, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Regulation FD disclosure
Jul 2, 2025
8-K
Director or officer change; Shareholder vote results
Jun 11, 2025
8-K
Regulation FD disclosure
Jun 4, 2025
8-K
Regulation FD disclosure
May 13, 2025
10-Q
Quarter ended 2025-03-31
May 9, 2025
8-K
Results of operations (earnings release)
May 8, 2025
8-K
Director or officer change
Mar 28, 2025
10-K
Fiscal year ended 2024-12-31
Mar 14, 2025
8-K/A
Results of operations (earnings release)
Mar 14, 2025
8-K
Regulation FD disclosure
Mar 10, 2025
8-K
Regulation FD disclosure
Mar 3, 2025
8-K
Results of operations (earnings release)
Feb 27, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Feb 27, 2025
8-K
Entered a material agreement
Jan 21, 2025
8-K
Regulation FD disclosure
Jan 14, 2025
8-K
Regulation FD disclosure
Nov 14, 2024
8-K
Director or officer change
Nov 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Nov 8, 2024
8-K
Regulation FD disclosure
Nov 8, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Other events
Oct 7, 2024
8-K
Regulation FD disclosure
Sep 4, 2024